Z SQUARED INC (ZSQR)
Health Care · cryptocurrency mining · NASDAQ
Z Squared Inc. is a digital asset mining company operating a fleet of thousands of ASIC mining machines, following a strategic pivot from its legacy biopharmaceutical focus.
What Z SQUARED INC does
Z Squared Inc. is a holding company primarily engaged in cryptocurrency mining operations, utilizing a fleet of approximately 9,800 ASIC mining machines. Following a 2026 merger and corporate reorganization, the company retains GEAR Therapeutics, Inc., an entity focused on cell therapy development, though its primary business focus shifted toward high-density compute and digital asset mining infrastructure.
Recent developments
On April 24, 2026, the company completed a merger with Old Z Squared, resulting in a name change to Z Squared Inc. and the acquisition of a large fleet of ASIC mining machines. Concurrently, the company spun out its legacy biopharmaceutical operations, retaining only GEAR Therapeutics, Inc. under a potential future acquisition option held by the spun-out entity.
From Z SQUARED INC's filing of 2026-08-13.
Themes: cryptocurrency mining, digital assets, high-density compute infrastructure
Fundamentals
- Price$3.60 as of 2026-10-21 close
- Market cap$191M as of 2026-08-11 (share count; price 2026-10-21)
- 1-year return-76.0% 2025-10-21 close $15.01 → 2026-10-21 close $3.60
- P/En/a negative earnings
- Net margin-874.3% FY2025, SEC XBRL
- Gross margin+86.7% FY2025, SEC XBRL
- ROE-87.9% FY2025, SEC XBRL
- ROICn/a No figure: its pre-tax income was zero or negative, so there is no tax rate to apply.
- Debt / equityn/a No figure: its filing tags none of the debt lines we read, which is not evidence of zero debt.
- Beta0.66 as of 2026-09-02
- Last reported earningsn/a no earnings announcement (Form 8-K, Item 2.02) has been filed in our data yet
How ZSQR compares in its sector
- net profit marginbottom 25% 430 covered Health Care peers, as of 2026-09-02
- operating marginbottom 25% 417 covered Health Care peers, as of 2026-09-02
- gross margintop 10% 189 covered Health Care peers, as of 2026-09-02
- return on equitybottom 25% 510 covered Health Care peers, as of 2026-09-02
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Quarterly results
| Quarter | Revenue | Gross profit | Operating income | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-30 | $2M | -$2M | -$14M | -$14M | -$0.28 | $2M† |
| Q1 FY2026 2026-03-31 | $113771 | $68615 | -$4M | -$30 | -$0.65 | -$2M |
| Q4 FY2025 2025-12-31 | $862049† | $816892† | -$2M† | -$1M† | -$0.12† | -$2M† |
| Q3 FY2025 2025-09-30 | $237441 | $192286 | -$2M | -$3M | -$0.58 | -$7M† |
| Q2 FY2025 2025-06-30 | $0 | $0 | $0 | $0 | $0.00 | $2M† |
| Q1 FY2025 2025-03-31 | $62874 | $17718 | -$4M | -$3M | -$1.10 | -$2M |
| Q4 FY2024 2024-12-31 | — | $0† | -$2M† | -$3M† | -$5.35† | -$1M† |
| Q3 FY2024 2024-09-30 | $0 | $0 | -$2M | -$2M | -$0.05 | -$2M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$15M
- Total debtnot shown the filing tags none of the debt lines we read — not evidence of zero debt
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How Z SQUARED INC looks technically
Z SQUARED INC (ZSQR) is trading 60.7% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 152 trading days ago — a "death cross", a bearish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 27, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 44, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 2 trading days ago (its momentum flipped negative). It made a new 20-day high about 8 trading days ago. It is 82.8% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 60.7% below its 200-day average, the long-term trend line — a long-term downtrend | -60.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $3.74 | $3.74 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $9.40 | $9.40 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 11 calendar days ago — the swings before that are what the structure reading is measured on | 11 sessions |
| Wave structure | its recent swings can be read as a completed three-part upward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes above 5.89. It is the only labelling that fits, and it describes the swings already printed, not what comes next. | possible three-wave upward correction, complete |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 152 trading days ago — a "death cross", a bearish long-term signal | 152 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 27, with buyers in control | 26.8 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 44, neither overbought (above 70) nor oversold (below 30) | 43.7 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($3.36 to $5.89) — its "stochastic" reading is 13 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 13.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 2 trading days ago (its momentum flipped negative) | 2 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $21.41 | $21.41 |
|---|---|---|
| From the 52-week high | it is 82.8% below its 52-week high (its highest price of the past year) | -82.8% |
| Above the 52-week low | it is 74.9% above its 52-week low (its lowest price of the past year) | +74.9% |
| Below the 52-week high | it is 82.8% below its highest point of the past year | 82.8% |
| Since a 20-day breakout | it made a new 20-day high about 8 trading days ago | 8 sessions |
| Since a 55-day breakout | it made a new 55-day high about 8 trading days ago | 8 sessions |
| All-time high | its highest closing price on record is $428.40 (set on 2022-10-28) | $428.40 |
| Given back of the 52-week move | over the past year its closes ranged ($2.29 to $18.80), and it has recovered only a small part of its fall from last year’s high — 8% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $12.49 to $13.02. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 8.5% |
| From the all-time high | it is 99.1% below its all-time high | -99.1% |
| Nearest price level | it is trading 8.3% above a support level at $3.38 — a price it turned at twice since 2026-09-10, most recently on 2026-10-02. Since 2024-10-21 it has 1 such level below the current price and 11 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -8.3% |
| All-time low | its lowest closing price on record is $2.11 (set on 2026-09-15) | $2.11 |
| Above the all-time low | it is 74.9% above its all-time low | +74.9% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 41st percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.611 between its high and its low — about 16.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.611 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $3.04 and $5.58 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $3.04 – $4.31 – $5.58 |
| Typical daily range (% of price) | its price moves about 16.6% in a typical session — among the most volatile in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 16.6% |
| Stretch from the 200-day average | it is trading 9.3 daily ranges below its 200-day average price (60.7% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 9.3 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.58× |
|---|
Candlestick patterns
1
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-10-20 0.3% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.3% |
|---|---|---|
| Open gap | it gapped 4.1% above the previous close 18 sessions ago and has not traded back through the level it left behind at 2.96 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +4.0% |
| Gap filled | a 2.4% gap down opened on 2026-10-14 has been "filled" 4 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 4 sessions ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 36.7 percentage points (the stock gained 37.7% while the market gained 1.0%) | +36.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 22.1 percentage points (the stock lost 18.5% while the market gained 3.6%) | -22.1% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 84.8 percentage points (the stock lost 76.3% while the market gained 8.5%) | -84.8% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 90.2 percentage points (the stock lost 75.6% while the market gained 14.6%) | -90.2% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, MACD momentum is negative, lagging the market over 6 months — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is thick, spanning 110.6% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | 0.0% |
|---|
Volume-weighted price
1
| Vs this year’s average price paid | the price is 53% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $7.93 — a volume-weighted average of daily closes over 200 sessions, not a true tick-by-tick VWAP. | -53.5% |
|---|
Price levels it has turned at before
ZSQR last closed at $3.69 on 2026-10-20. Since 2024-10-21 it has turned at 1 price below its last close and 11 above; the nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $3.38 | Support | 8.3% below the last close | turned there twice · 2026-09-10 to 2026-10-02 |
| $6.81 | Resistance | 84.5% above the last close | turned there twice · 2024-12-26 to 2025-06-20 |
| $8.98 | Resistance | 143.3% above the last close | turned there five times · 2025-03-28 to 2026-04-27 |
| $9.76 | Resistance | 164.4% above the last close | turned there twice · 2026-03-24 to 2026-06-09 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part upward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes above $5.89.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This reading has stood for 3 trading days, since 2026-10-16.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Pulled back from the 12-month high · MACD just crossed bearish (12/26/9) · in a strong, established uptrend (ADX) · lagging the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Key risks (from latest filing)
["Significant dependence on the volatile price of digital assets and the profitability of cryptocurrency mining.","Operational risks associated with high-density compute infrastructure and ASIC mining machine performance.","Complex corporate structure and potential future divestiture of remaining therapeutic assets via existing options."]
What changed in the latest 10-Q
AI-assisted comparison of ZSQR's 10-Q filed 2026-05-15 against the prior one filed 2025-11-14.
Management's Discussion & Analysis (MD&A)
- Added:
- Recent Business Combination section describing April 24, 2026 merger with Z Squared, Inc. and issuance of 43,877,497 shares
- Corporate name change from Coeptis Therapeutics Holdings, Inc. to Z Squared Inc. effective April 27, 2026
- Nasdaq ticker symbol change from COEP to ZSQR
- Description of Spin-Out of biopharmaceutical operations to spin-out subsidiaries (Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., Coeptis Pharmaceuticals, LLC, SNAP Biosciences, Inc.)
- Description of principal business as digital asset mining operations including cryptocurrency mining of Dogecoin (DOGE), Litecoin (LTC), and other digital assets at facilities in North Carolina, South Carolina, and Iowa
- Description of complementary business lines including power generation, data center development, and high-performance compute hosting
- Retention of interest in GEAR Therapeutics, Inc. following Spin-Out
- Reference to Registration Statement on Form S-4 (File No. 333-288329) declared effective December 23, 2025
- Reference to Current Report on Form 8-K filed April 24, 2026
- Basis of MD&A Discussion section explaining historical financial statements represent pre-Merger business of legal acquirer
- Caveat that historical financial information is not indicative of or comparable to subsequent periodic reports
- Expanded forward-looking statements language including additional qualifiers: anticipate, plan, may, will, should, would, could, potential, future
- Removed:
- Reference to Merger accounted for as reverse merger with Coeptis Therapeutics, Inc. as accounting acquirer
- Company History section describing incorporation in British Virgin Islands on November 27, 2018 and domestication to Delaware
- Company History describing October 28, 2022 merger with Coeptis Therapeutics, Inc.
- About the Company's Subsidiaries section describing SNAP Biosciences, Inc. and GEAR Therapeutics, Inc. as majority owned, and Coeptis entities as wholly owned
- Company History of Coeptis Therapeutics, Inc. section with detailed formation and merger history
- Overview and Outlook section describing biopharmaceutical and technology company focused on cell therapy technologies for cancer
- Description of two 505b2 anti-hypertension products approved and launched in 2020
- Description of ANDA products divested in 2019
- Reference to strategic partnerships for auto-immune and oncology markets
- Objective section explaining MD&A purpose and context
- Reference to Form 10-K and three and nine months ended September 30 periods
- Specific risk factors reference to failure to develop profitable business, delays in identifying customers, inability to retain customers
- Reworded:
- Forward-looking statements section moved earlier in document structure (after Recent Business Combination rather than before Objective)
- Forward-looking statements now includes Section 21E of Securities Exchange Act of 1934 instead of Section 12E
- Forward-looking statements now specifies reverse acquisition accounting terminology instead of reverse merger
- Financial statements now described as covering three months ended March 31, 2026 and 2025 instead of three and nine months ended September 30
- MD&A scope changed from Coeptis Therapeutics, Inc. and subsidiaries to historical pre-Merger company as legal acquirer
- MD&A explicitly excludes operations of Z Squared as accounting acquirer and Spin-Out Subsidiaries from current period presentation
- Notes:
- Older filing text appears truncated at end (ends mid-sentence with 'innovativ')
- Newer filing text also appears truncated at end of Forward-Looking Statements section (ends mid-sentence)
- Comparison based on available text; full extent of changes may be obscured by truncation
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
2 open-market purchases and 0 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 6 days since 2026-10-16 have not been checked yet.
- Last 90 days · read to 2026-10-162 buys ($7840) · 0 sells — 1 buying insider
- Last 180 days · read to 2026-10-162 buys ($7840) · 0 sells — 1 buying insider
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-18. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ZSQR's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
2 institutional 13F filers reported holding ZSQR as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 2
- Reported shares held 2,520,875
- Reported value $26,670,858
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ZSQR's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ZSQR had 4,536,025 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
ZSQR had 8.56% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 9.45 days to cover at the same settlement.
- Reported short interest (shares) 4,536,025
- Short interest (% of shares outstanding) 8.56%
- Prior settlement (shares) 4,112,942
- Reported change 10.29%
- Days to cover (reported) 9.45
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Marathon Digital Holdings (MARA)
- Riot Platforms (RIOT)
- CleanSpark (CLSK)
- Core Scientific (CORZ)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ZSQR vs…
Z SQUARED INC is found in…
Frequently asked questions
What does Z SQUARED INC (ZSQR) do?
Z Squared Inc. is a holding company primarily engaged in cryptocurrency mining operations, utilizing a fleet of approximately 9,800 ASIC mining machines. Following a 2026 merger and corporate reorganization, the company retains GEAR Therapeutics, Inc., an entity focused on cell therapy development, though its primary business focus shifted toward high-density compute and digital asset mining infrastructure.
What sector is Z SQUARED INC (ZSQR) in?
Z SQUARED INC (ZSQR) is classified in the Health Care sector. Its industry is cryptocurrency mining. It trades on NASDAQ.
Who are Z SQUARED INC's (ZSQR) competitors?
Notable peers of Z SQUARED INC (ZSQR) include Marathon Digital Holdings, Riot Platforms, CleanSpark and Core Scientific. This peer set is informational only — not financial advice.
Is Z SQUARED INC (ZSQR) overbought or oversold right now?
Z SQUARED INC (ZSQR) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 44, in the neutral middle (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ZSQR come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.